Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update
2020-08-10 19:30
Volition Announces Promising Clinical Trials Results for its Novel COVID-19 Triage Test
2020-07-14 18:00
VolitionRx Releases Business Update Video and Announces Addition to the Russell 3000® and Russell Microcap® Indexes
2020-06-25 20:45
Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference
2020-05-27 20:45
VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock
2020-05-23 04:01
VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock
2020-05-20 20:45
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
2020-05-20 04:01
VolitionRx To Present First Data on Nu.Q™ Capture Performance and Nu.Q™ Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting
2020-05-14 06:54
VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update
2020-05-08 04:10
VolitionRx Limited Schedules First Quarter 2020 Earnings Conference Call and Business Update
2020-05-05 20:30
Volition's Nu.Q™ Vet Assay Detects Two Common Canine Cancers
2020-04-29 20:30
Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies
2020-04-23 20:30
VolitionRx Limited Releases Annual Corporate Brochure and Video
2020-03-10 20:45
VolitionRx Limited to Present at Conferences in March 2020
2020-03-03 21:30
VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update
2020-02-21 05:10
VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update
2020-02-19 05:10
Volition Unveils Its Epigenetic Toolbox
2020-02-18 21:30
VolitionRx Announces Filing of Registration Statements
2020-02-08 06:30
Volition Develops a New Improved Nu.Q™ Assay Format
2020-01-13 22:00
VolitionRx Completes Acquisition of Octamer GmbH
2020-01-10 21:00
1
2
3
4
5
7